Resveratrol-activated PI3K/AKT/mTOR signaling pathway attenuates ferroptosis by promoting NRF2/GPX4 metabolic pathway to mitigate IFN-gamma-mediated aplastic anemia
Open Access
- 8 July 2026
- journal article
- research article
- Published by Springer Nature in Chinese Medicine
- Vol. 21 (1) , 185
Abstract
Background: Aplastic anemia (AA) is a severe hematological disorder caused by hyperactivated T cell-mediated hematopoietic failure. It is characterized by hematopoietic stem cell deficiency and hypocellular hematopoiesis in the bone marrow (BM). Ferroptosis, a specific type of programmed cell death, is defined by iron-dependent lipid peroxidation, which has garnered the attention of researchers due to its unique role and biological importance in various diseases. However, the correlation between immunological imbalance-induced ferroptosis and the mortality of hematopoietic stem cells within the BM microenvironment in AA is unclear. Resveratrol (RSV) is crucial in activating NRF2, hence influencing the onset and progression of diseases by regulating ferroptosis. This study aimed to investigate the roles and molecular mechanisms of RSV in the hematopoietic recovery of AA regarding ferroptosis. Methods: We measured some biomarkers in AA mice and IFN-gamma-treated 32D cells, representing AA syndromes and ferroptosis features. Furthermore, in RSV-treated 32D AA cells, cell activity, cell apoptosis, mitochondrial membrane potential, mitochondrial membrane permeability, and intracellular levels of MDA, ferrous iron, 4-HNE, GSH, ROS, and lipid peroxidation were assessed. Subsequently, additional in vitro and in vivo experiments were performed to investigate the mechanisms by which RSV effectively regulates NRF2 stability, further inhibiting ferroptosis in AA. Results: We demonstrated that ferroptosis contributes to the occurrence and development of AA disease. RSV dose-dependently inhibits ferroptosis in 32D AA cells by targeting GPX4 expression, enhancing the cell activity of hematopoietic BM cells. Mechanically, RSV significantly increases NRF2 phosphorylation through the PI3K/AKT/mTOR signaling pathway, which maintains NRF2 stability to promote the GPX4 metabolic pathway in AA. Protein levels of p-AKT, p-mTOR, p-NRF2, and GPX4 were markedly increased in BM cells in RSV-treated AA mice, resulting in the suppression of AA development. Conclusion: Our data demonstrate that RSV effectively inhibits ferroptosis in AA or IFN-gamma-treated 32D cells by targeting the PI3K/AKT/mTOR signaling pathway, which enhances NRF2-mediated GPX4 transcription, thereby ameliorating AA symptoms in vitro and in vivo. This study concludes that RSV is a potential therapeutic drug for ferroptosis-related AA treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81903154)
- China Postdoctoral Science Foundation funded project (2022M711722)
- Grants from Jiangsu Provincial Research Hospital (YJXYY202204)
- grants from the Nantong Health Commission Project (QN2023007)
- Clinical Medicine Research Project of Nantong University (2024LZ026)
This publication has 45 references indexed in Scilit:
- Ferroptosis: molecular mechanisms and health implicationsCell Research, 2020
- Anemia of inflammationBlood, 2019
- Aplastic AnemiaNew England Journal of Medicine, 2018
- Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injuryAging, 2018
- Recent advances in understanding clonal haematopoiesis in aplastic anaemiaBritish Journal of Haematology, 2017
- IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failureBlood, 2015
- Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal networkNature Medicine, 2015
- Impact of interferon-γ on hematopoiesisBlood, 2014
- Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in miceFree Radical Biology and Medicine, 2013
- Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemiaBlood, 2012